97
Views
2
CrossRef citations to date
0
Altmetric
Research Papers

Cross-sectional study of risk factors for atherosclerosis in the Azorean population

, , , , , , , , , & show all
Pages 354-359 | Received 29 Oct 2010, Accepted 04 Jan 2011, Published online: 15 Feb 2011

References

  • Addinsoft. 2010. XLSTAT 2010. Available online at http://www.xlstat.com, accessed 30 September 2010..
  • Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, Danesh J. 2007. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 298:1300–1311.
  • Bettencourt C, Montiel R, Santos C, Pavão ML, Viegas-Crespo AM, Lopes PA, Lima M. 2006. Polymorphism of the APOE locus in the Azores Islands (Portugal). Hum Biol. 78:509–512.
  • Bruges-Armas J, Lima C, Peixoto MJ, Santos P, Mendonça D, da Silva BM, Herrero-Beaumont G, Calin A. 2002. Prevalence of spondyloarthritis in Terceira, Azores: a population based study. Ann Rheum Dis. 61:551–553.
  • Burman D, Mente A, Hegele RA, Islam S, Yusuf S, Anand SS. 2009. Relationship of the ApoE polymorphism to plasma lipid traits among South Asians, Chinese, and Europeans living in Canada. Atherosclerosis. 203:192–200.
  • Casas JP, Bautista LE, Humphries SE, Hingorani AD. 2004. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation. 109:1359–1365.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJr, Jones DW, Materson BJ, Oparil S, Wright JTJr, Roccella EJ. 2003. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 289:2560–2572.
  • David D, Ribeiro S, Ferrão L, Gago T, Crespo F. 2004. Molecular basis of inherited antithrombin deficiency in Portuguese families: identification of genetic alterations and screening for additional thrombotic risk factors. Am J Hematol. 76:163–171.
  • Di Pasquale P, Cannizzaro S, Paterna S. 2004. Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects. Eur J Heart Fail. 6:11–16.
  • Direcção-Geral da Saúde, editor. Elementos estatísticos, Informação Geral – Saúde/ 2007. Lisbon. 2009 [ISSN 0872-1114].
  • Eichner JE, Dunn ST, Perveen G, Apolipoprotein E, Thompson DM, Stewart KE, Stroehla BC. 2002. polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 155:487–495.
  • Excoffier L, Laval G, Schneider S. 2005. Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online. 1:147–150.
  • Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of the Third REFERENCES Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285:2486–2497.
  • Ferrer-Antunes C, de Maat MP, Palmeiro A, Pimentel J, Fernandes V. 1998. Association between polymorphisms in the fibrinogen alpha- and beta-genes on the post-trauma fibrinogen increase. Thromb Res. 92:207–212.
  • Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:499–502.
  • Garcés C, López-Simón L, Rubio R, Benavente M, Cano B, Ortega H, de Oya M. 2008. High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain. Clin Chem Lab Med. 46:809–813.
  • Gialeraki A, Politou M, Rallidis L, Merkouri E, Markatos C, Kremastinos D, Travlou A. 2008. Prevalence of prothrombotic polymorphisms in Greece. Genet Test. 12:541–547.
  • Hanis CL, Hewett-Emmett D, Douglas TC, Bertin TK, Schull WJ. 1991. Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Arterioscler Thromb. 11:62–70.
  • Henskens LH, Spiering W, Stoffers HE, Soomers FL, Vlietinck RF, de Leeuw PW, Kroon AA. 2003. Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocates study. J Hypertens. 21:81–86.
  • Howard BV, Gidding SS, Lui K. 1998. Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults: the CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol. 148:859–868.
  • INE. 2006. Estimation of resident population 2001 based on provisory results of Census 2006. Portugal: National Institute of Statistics (in Portuguese).
  • Jia CQ, Zhao ZT, Wang LH, Hao FR, Feng YQ, Wang SM, Xu XF, Jia CX. 2003. Effects of G894T mutation in the endothelial nitric oxide synthase gene on blood pressure. Zhonghua Liu Xing Bing Xue Za Zhi. 24:36–39.
  • Knowles JW, Wang H, Itakura H, Southwick A, Myers RM, Iribarren C, Fortmann SP, Go AS, Quertermous T, Hlatky MA. 2007. Association of polymorphisms in platelet and haemostasis system genes with acute myocardial infarction. Am Heart J. 154:1052–1058.
  • Lima M, Costa MC, Montiel R, Ferro A, Santos C, Silva C, Bettencourt C, Sousa A, Sequeiros J, Coutinho P, Maciel P. 2005. Population Genetics of wild-type CAG repeats in the Machado-Joseph disease (MJD) gene in Portugal. Hum Hered. 60:156–163.
  • Mackness MI, Mackness B, Durrington PN, Fogelman AM, Berliner J, Lusis AJ, Navab M, Shih D, Fonarow GC. 1998. Paraoxonase and coronary heart disease. Curr Opin Lipidol. 9:319–324.
  • Magro F, Dinis-Ribeiro M, Araújo FM, Pereira P, Fraga MC, Cunha-Ribeiro LM, Tomé-Ribeiro A. 2003. High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 15:1157–1163.
  • Marian AJ, Brugada R, Kleiman NS. 1996. Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction. N Engl J Med. 335:1071–1072.
  • Matos AT. 1989. Origem e reminiscências dos povoadores das ilhas atlânticas. In: Comissão Nacional para as Comemorações dos Descobrimentos Portugueses, editors. Actas do Congresso Internacional Bartolomeu Dias e a Sua Época, Universidade do Porto, Porto. p 241–252..
  • Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Lopes C. 2002. Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev. 11:343–350.
  • Mendonça L. 1996. Azores History – General Vision (centuries XV to XIX). Ponta Delgada, Azores. Portugal: Centre of Tecnological Suport to Education (in Portuguese).
  • Mendonça MI, Dos Reis RP, Freitas AI, Sousa AC, Pereira A, Faria P, Gomes S, Silva B, Santos N, Serrão M, Ornelas I, Freitas S, Araújo JJ, Brehm A, Cardoso AA. 2008. Human paraoxonase gene polymorphisms and coronary artery disease risk. Rev Port Cardiol. 27:1539–1555.
  • Montiel R, Bettencourt C, Silva C, Santos C, Prata MJ, Lima M. 2005. Analysis of Y-chromosome variability and its comparison with mtDNA variability reveals different demographic histories between Islands in the Azores Archipelago. Ann Hum Genet. 69:1–10.
  • Nei M. 1978. Estimation of average heterozygosity and genetic distance from a small number of individuals. Genetics. 89:583–590.
  • Onalan O, Balta G, Oto A, Kabakci G, Tokgozoglu L, Aytemir K, Altay C, Gurgey A, Nazli N. 2008. Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease. J Thromb Thrombolysis. 26:211–217.
  • Renner W, Cichocki L, Forjanics A, Köppel H, Gasser R, Pilger E.. 2002. G-455A. polymorphism of the fibrinogen beta gene and deep vein thrombosis. Eur J Clin Invest. 32:755–758.
  • Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. 1997. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction stroke, and venous thrombosis. Lancet. 349:385–388.
  • Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86:1343–1346.
  • Rodrigues MO, Fonseca A, Matias-Dias C, Albergaria I, Martins G, Alpendre ML, do Martins MC. 2005. APOE genotypes and dyslipidemias in a sample of the Portuguese population. Clin Chem Lab Med. 43:907–912.
  • Roy H, Bhardwaj S, Yla-Herttuala S. 2009. Molecular genetics of atherosclerosis. Hum Genet. 125:467–491.
  • Sabbagh AS, Otrock ZK, Mahfoud ZR, Zaatari GS, Mahfouz RAR. 2007. Angiotensin-converting enzyme gene polymorphism and allele frequencies in the Lebanese population: prevalence and review of the literature. Mol Biol Rep. 34:47–52.
  • Salonen JT, Malin R, Tuomainen TP, Nyyssonen K, Lakka TA, Lehtimaki T. 1999. Polymorphism in high-density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study. Br Med J. 319:487–489.
  • Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. 1996. A meta-analysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial infarction. Circulation. 94:708–712.
  • Santos C, Alvarez L, Aluja MP, Bruges-Armas J, Lima M. 2009. Genetic structure of the Azores Islands: a study using 15 autosomal short tandem repeat loci. Coll Antropol. 33:991–999.
  • Santos C, Lima M, Montiel R, Anglés N, Pires L, Abade A, Aluja MP. 2003. Genetic structure and origins of peopling in the Azores Islands (Portugal): the view from mtDNA. Ann Hum Genet. 67:433–456.
  • Sawada T, Kishimoto T, Osaki Y, Okamoto M, Tahara A, Kaetu A, Kurosawa Y, Kotani K. 2008. Relation of the Glu298Asp polymorphism of the nitric oxide synthase gene to hypertension and serum cholesterol in Japanese workers. Prev Med. 47:167–171.
  • Schreyer SA, Vick CM, LeBoeuf RC. 2002. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J Biol Chem. 277:12364–12368.
  • Sing CF, Davignon J. 1985. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 37:268–285.
  • Trompet S, de Craen AJM, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Bollen ELEM, Buckley BM, Ford I, Gawh A, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RGJ, Jukema JW, on behalf of the PROSPER Group. 2008. Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study. Exp Gerontol. 43:801–805.
  • Zhang Y, Zheng F, Du H, Krepinsky JC, Segbo JA, Zhou X. 2006. Detecting the polymorphisms of paraoxonase (PON) cluster in Chinese Han population based on a rapid method. Clin Chim Acta. 365:98–103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.